Retraction
Role of methyle blue in the management of mild, moderate and severe COVID-19 disease
Paper Information
Record ID:
41886
Journal:
Publication Date:
February 16, 2022
Retraction Date:
October 31, 2022
(3.1 years years ago)
Subjects:
Institution:
Department of Medicine, Bawaskar Hospital and Clinical Research Centre, Mahad, Raigad, Maharashtra, IndiaCountry:
🇮🇳 IndiaArticle Type:
Publisher:
Wolters Kluwer - Lippincott Williams & Wilkins
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (5)
5
Total Citations1
Post-Retraction(20.0%)
3
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
0
After 2+ years
534
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
The critical impacts of cytokine storms in respiratory disorders
Shahana Riyaz Tramboo, Ahmed M. E. Elkhalifa, Syed Quibtiya et al. (25 authors)
Heliyon
Open Access
Published: Apr 2024
7 citations
7 citations
534 days after retraction
Retraction: Role of methyle blue in the management of mild, moderate and severe COVID-19 disease
Unknown Authors
Journal of Family Medicine and Primary Care
Open Access
Published: Oct 2022
30 days before retraction
Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19
Sung-Ting Chuang, Henrietta Papp, Anett Kuczmog et al. (8 authors)
Pharmaceuticals
Open Access
Published: May 2022
15 citations
15 citations
166 days before retraction
Methylene Blue Is a Nonspecific Protein-Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19
Sung-Ting Chuang, Henrietta Papp, Anett Kuczmog et al. (8 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Mar 2022
5 citations
5 citations
223 days before retraction
Quick Stats
Total Citations:
8
Years Since Retraction:
3.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025